Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia

BACKGROUND: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as an inhibitor of angiogenesis and is associated with an increased risk of cardiovascular mortality. Administration of stem cells may affect endogenous mechanisms that regulate ADMA production and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Madaric, Juraj, Valachovicova, Martina, Paulis, Ludovit, Pribojova, Jana, Mateova, Renata, Sebekova, Katarina, Postulkova, Luba, Madaricova, Terezia, Bucova, Maria, Mistrik, Martin, Vulev, Ivan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5506609/
https://ncbi.nlm.nih.gov/pubmed/28697789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-017-0622-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars